Navigation Links
Generex Touts Pipeline Potential of Antigen Express Subsidiary
Date:2/7/2013

platform.  This technology enhances delivery of key target proteins like HER2 for cancer to a critical immune recognition site enhancing immune recognition. The Company has also developed compounds designed for important non-HER2 cancer associated protein targets using the Ii-Key technology platform. These include the melanoma-associated gp100 target, as well as cervical and head-and-neck cancers associated with Human Papilloma Virus (HPV). These compounds have shown significant activity in animal models that has been described in peer-reviewed publications.

In addition to cancer protein targets, the Company has clinically tested Ii-Key-based proteins designed to protect against the potentially pandemic influenza strains H5N1 (avian flu) and H1N1 (swine flu). The advantage here is that the Antigen vaccine technology is entirely synthetic, making it simple to manufacture. In the event of a potentially pandemic influenza virus, there is clearly a need for this type of flexible vaccine technology that can be brought into production rapidly.

The distinguishing feature of Antigen Express technology (Ii-Key) is the ability to activate critical components of the immune system (CD4+ T helper cells) in a robust and specific manner. Currently this is a unique technology platform that directs proteins to a critical immune component to be able to create specific immune stimulation. This Ii-Key technology is proprietary to Antigen Express. Consequently, the Company is in a good position to license the technology for combination with multiple different target proteins to create novel vaccine applications that may be of interest to other researchers and companies.

About Generex Biotechnology Corporation

Generex is engaged in the research, development, and commercialization of drug delivery systems and technologies. Generex has developed a proprietary platform technology for the delivery of drugs into the human body through the oral cavit
'/>"/>

SOURCE Generex Biotechnology Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Generex Announces Presentations of Antigen Express AE37 Breast Cancer Vaccine Data at ASCO 2012
2. Generex Announces New Members of Antigen Express Scientific Advisory Board for the AE37 Breast Cancer Vaccine
3. Generex Augments Antigen Express Scientific Advisory Board
4. Generex Reports on Inaugural AE37 Breast Cancer Vaccine Scientific Advisory Board Meeting
5. Generex Announces OncUView.tv Interviews Featuring the Antigen Express AE37 Breast Cancer Vaccine at ASCO 2012
6. Generex Announces Results of Annual Stockholders Meeting
7. Generex Addresses Recent Trading Volume in Shares of its Common Stock
8. Generex Announces Details of Investor Conference Call
9. Generex Provides an Overview of its Cancer Immunotherapy Product, AE37, and Potential in Early Breast Cancer Given Current and Potential Future Therapies
10. Generex Points to Potential of Antigen Express Technology Platform beyond Its AE37 Breast Cancer Vaccine
11. Lilly Sets Date for Lilly Diabetes Pipeline Update to the Investment Community
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/31/2015)... , March 31, 2015 Accelerated ... the American Association of Orthodontics 2015 Annual Session, ... orthodontists present scientific lectures on AcceleDent ® . ... leader in accelerated orthodontics, AcceleDent is a FDA-cleared, ... treatment by as much as 50 percent with ...
(Date:3/31/2015)... DALLAS , March 31, 2015 ... H1 2015" therapeutic market research report of 68 ... its online business intelligence library. The ... information on the therapeutic development for Pemphigus ... therapeutics assessment by drug target, mechanism of action ...
(Date:3/31/2015)... Ryan & Maniskas, LLP is ... Hyperion Therapeutics, Inc. ("Hyperion" or the "Company") (NASDAQ: ... other violations of law related to the Company,s efforts ... a transaction valued at approximately $1.1 billion. ... to learn more about this class action or if ...
Breaking Medicine Technology:Leading Orthodontists to Advance Accelerated Treatment at AAO 2015 2Leading Orthodontists to Advance Accelerated Treatment at AAO 2015 3Pemphigus Therapeutic Development and Pipeline Review H1 2015 2Pemphigus Therapeutic Development and Pipeline Review H1 2015 3Pemphigus Therapeutic Development and Pipeline Review H1 2015 4Ryan & Maniskas, LLP Announces Investigation of Hyperion Therapeutics, Inc. 2
... 25, 2011 Renowned biochemist Michael A. Marletta, ... as the next president of The Scripps Research Institute, effective ... MD, who has led the institution for 25 years. ... Marletta, past Chair of the Department of ...
... 2011 ERT (Nasdaq: ERES ), announced ... CEO, and Keith Schneck, the Company,s Chief Financial Officer, ... Health Care Conference at 10:00 AM ET on March 2, ... may access the presentation by visiting the Company,s corporate ...
Cached Medicine Technology:The Scripps Research Institute Names Michael A. Marletta as President 2The Scripps Research Institute Names Michael A. Marletta as President 3The Scripps Research Institute Names Michael A. Marletta as President 4ERT to Present at the Citi 2011 Global Health Care Conference on March 2, 2011 2
(Date:3/31/2015)... (PRWEB) March 31, 2015 Medical DNA ... has met all criteria for Laboratory Accreditation by COLA, ... only to laboratories that apply rigid standards of quality ... of proficiency testing, and pass a rigorous on-site laboratory ... accreditation as a result of a long-term commitment to ...
(Date:3/31/2015)... 31, 2015 Students, teachers, and the ... education in a drastically different way as current and ... and training content is being delivered and received. , ... technology in an unprecedented way with education becoming individualized, ... co-founder and CEO, My Mobile University , This ...
(Date:3/31/2015)... Clinovo, a leading provider of ... , the premiere voice of Northern California’s Life ... companies. , BayBio brings together the collective ... and productive life science cluster, helping companies grow, ... most pressing challenges. , “We are thrilled ...
(Date:3/31/2015)... 31, 2015 Dr. Russell Ashinoff is a ... He was recently quoted in an Asbury Park Press ... issues, causing fluid retention and tissue swelling. Dr. Ashinoff ... and / or improve lymphedema symptoms. , “The ... the symptoms of lymphedema. The goal is to improve ...
(Date:3/31/2015)... (PRWEB) March 31, 2015 Dr. Uzma Parvez ... March 19th, Dr. Parvez conducted Grand Grounds Presentations at St. ... Opioids and Managing Side Effects”. The event was attended ... She received very positive feedback from the Grand Rounds. ... best that they’ve had in a while. , Ahead, ...
Breaking Medicine News(10 mins):Health News:Local Medical DNA Labs, LLC. Recognized for Quality Laboratory Services 2Health News:LTT Global Communications Launches First Asia Holistic Online Learning Platform 2Health News:LTT Global Communications Launches First Asia Holistic Online Learning Platform 3Health News:Clinovo Joins BayBio Membership Program, The Leading Life Science Association in Northern California 2Health News:The Physicians at Plastic Surgery Center Each Have Something to Celebrate This March 2Health News:The Physicians at Plastic Surgery Center Each Have Something to Celebrate This March 3Health News:The Physicians at Plastic Surgery Center Each Have Something to Celebrate This March 4Health News:NJ Top Docs Presents, Dr. Uzma Parvez of Total Pain Care 2
... organizations have called on the medical profession to ... health between Indigenous and non-Indigenous Australians . ... of Australia, Dr Mark Wenitong, President of the ... the National Aboriginal Community Controlled Health Organization and ...
... Indigenous mothers living in remote areas are 14 per cent ... in regional or city areas say Indigenous health researchers ... Womens and Childrens Health at the University of New South ... Welfare National Perinatal Statistics Unit and her colleagues, examined whether ...
... the brain to sensitize people to overreact to an ... people who dont have a stress-related disorder, says new ... have long lasting effects on the brain and behavior ... But these subtle changes could increase susceptibility to mental ...
... the growing epidemic of diabetes in the US is out. ... . ,According to a drug trend report released ... cholesterol medications in total prescription drug spending growth in 2006. ... obesity a leading cause of diabetes are expected ...
... in the mouth like a popular breath-freshener could someday ... The innovative drug-delivery system was developed by Johns ... two-semester course, the seven-student team fabricated a thin film ... the child to swallow the vaccine. The dissolved medication ...
... become one of the first major universities in the country ... University officials intend to give the Fayetteville campus community ... the policy: the ban is scheduled to go into effect ... issue, said Mary Alice Serafini, assistant vice chancellor for student ...
Cached Medicine News:Health News:Trauma Exposure can Affect Brain Function Several Years After Event 2Health News:Spending on Diabetes Drugs Soars in US 2Health News:Students Devise Oral Quick-dissolve Strips for Rotavirus Vaccine 2Health News:Students Devise Oral Quick-dissolve Strips for Rotavirus Vaccine 3Health News:University of Arkansas to Ban Tobacco from Its Campus 2Health News:University of Arkansas to Ban Tobacco from Its Campus 3
...
View Mex-2 is designed for out-patient surgery, hospital rounds and house calls....
It is a magnifying headlight perfect for all applications and procedures where clear magnification and a natural white light increase accuracy and productivity....
... is powerful, lightweight, easy ... soft, durable foam silicone ... covered by machine washable ... headband easily adjusts to ...
Medicine Products: